 | | Vol. 14.21 – 9 June, 2023 |
| |
|
|
| Investigators explored the role of minor intron-containing genes and minor spliceosomes in cancer, taking prostate cancer as an exemplar.
[Molecular Cell] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors uncovered dual-phosphorylated form of sterol regulatory element-binding protein 1 (SREBF1), pY673/951-SREBF1 that acts as an androgen sensor, and dissociates from androgen receptor in androgen deficient environment, followed by nuclear translocation.
[Nature Communications] |
|
|
|
| Using a variety of in vitro and in vivo techniques, researchers showed that metastatic prostate cancer cells acquire a specific Na+/Ca2+ signature required for persistent invasion.
[EMBO Journal] |
|
|
|
| Scientists developed a novel bioink for the three-dimensional bioprinting of a coculture model that could be used to investigate the effect of hyaluronic acid on prostate cancer (PCa) behaviors and the mechanism underlying PCa-fibroblasts interaction.
[Biofabrication] |
|
|
|
| To elucidate antitumor mechanism of Morusin, cytotoxicity assay, cell cycle analysis, Western blotting, TUNEL assay, RNA interference, immunofluorescense, immunoprecipitation, reactive oxygen species measurement, and inhibitor study were applied.
[Phytotherapy Research] |
|
|
|
| Investigators examined the androgen independent human prostatic cancer cell line PC3 and found functional expression of proteinase-activated receptor 1 (PAR1) and PAR2, but not PAR4.
[American Journal Of Physiology-Cell Physiology] |
|
|
|
| Researchers investigated the activity of the natural compound piperine on prostate cancer cell line, followed by exploring its mechanistic inhibition on the RAC-alpha serine/threonine-protein kinase (AKT1) protein.
[Journal Of Biomolecular Structure & Dynamics] |
|
|
|
| To identify genes that modulated treatment response to these drugs, the authors performed three genome-wide CRISPR/Cas9 knockout screens in the metastatic CRPC cell line C4.
[Scientific Reports] |
|
|
|
| Scientists investigated the molecular action of triiodothyronine (T3) on the ERAD mechanism and unfolded protein response signaling in prostate cancer cells and also extensively examined the effect of T3 on androgenic signaling.
[Cellular Signalling] |
|
|
|
| Using a two-tier phenotypic screening platform, researchers identified bromocriptine mesylate as a potent and selective inhibitor of chemoresistant prostate cancer cells.
[Translational Oncology] |
|
|
|
|
| The authors discuss the origin, hierarchy, and plasticity of prostate cancer stem cells (PCSCs) and various cellular and metabolic signaling pathways involved in PCSC induction and maintenance.
[Cancer Biology & Medicine] |
|
|
|
|
| Adults and children with cancer will continue to benefit from world-class clinical trials led by the University of Birmingham thanks to a new £10 million grant from Cancer Research UK.
[University of Birmingham] |
|
|
|
|
| June 26 – 29, 2023
Boston, Massachusetts, United States |
|
|
|
|
|
| | Cedars Sinai Medical Center – Los Angeles, California, United States |
|
|
|
| | University of Texas MD Anderson Cancer Center – Houston, Texas, United States |
|
|
|
| | Eastern Virginia Medical School – Norfolk, Virginia, United States |
|
|
|
| | The Brady Urological Institute – Baltimore, Maryland, United States |
|
|
|
| | The Georgia Cancer Center – Augusta, Georgia, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
